SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-23-005852
Filing Date
2023-01-23
Accepted
2023-01-23 16:59:02
Documents
6

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tm234027d1_s3.htm S-3 607437
2 EXHIBIT 5.1 tm234027d1_ex5-1.htm EX-5.1 9487
3 EXHIBIT 23.1 tm234027d1_ex23-1.htm EX-23.1 2910
4 EX-FILING FEES tm234027d1_ex-filingfees.htm EX-FILING FEES 13120
5 GRAPHIC tm234027d1_s3img001.jpg GRAPHIC 21444
6 GRAPHIC tm234024d1_s3img001.jpg GRAPHIC 5595
  Complete submission text file 0001104659-23-005852.txt   671587
Mailing Address 200 BERKELEY ST. FL 19 BOSTON MA 02116
Business Address 200 BERKELEY ST. FL 19 BOSTON MA 02116 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Filer) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-269365 | Film No.: 23545060
SIC: 2834 Pharmaceutical Preparations